Search | TVST | ARVO Journals

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: A 24-Months Follow-up Study

Tomás Loureiro; Diogo Cabral; Catarina Rodrigues; Telmo Pereira; Catherine Français; Manuel Falcão; Gabriel Coscas; Florence Coscas

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1901.

Articles February 2020

Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration

PDF

Diogo Cabral; Florence Coscas; Telmo Pereira; Catherine Français; Carlos Geraldes; Rita Laiginhas; Catarina Rodrigues; Alexis Khorrami Kashi; Vanda Nogueira; Manuel Falcão; Ana Luísa Papoila; Marco Lupidi; Gabriel Coscas; Salomon Yves Cohen; Eric Souied
TAGS: angiogram, anti-vascular endothelial growth factor therapy, biological markers, choroidal neovascularization, drug loading dose, exudative age-related macular degeneration, follow-up, optical coherence tomography, regimen, vascular flow
Trans. Vis. Sci. Tech.. 2020; 9(3):18. https://doi.org/10.1167/tvst.9.3.18

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2017

Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study

Maddalena Quaranta; François DEVIN; Gabriel QUENTEL; Joël UZZAN; Eric Fourmaux; Laurent CASTELNOVO; Wilfried ROQUET; Catherine FRANCAIS-MAURY; Sam RAZAVI; Nathalie San Nicolas

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):900.

ARVO Annual Meeting Abstract June 2017

Aflibercept polypoidal choroidal vasculopathy treatment : Result of a prospective study

Martine Mauget-Faysse; Vasseur Vivien; Armelle Cahuzac; Florence Coscas; Laurent CASTELNOVO; Catherine Favard; Guillaume Michel; Catherine Français; Laurence Salomon; Benjamin Wolff

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3201.

ARVO Annual Meeting Abstract September 2016

Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naive patients enrolled in the ORACLE study

François Devin; Eric Fourmaux; gabriel quentel; Joel Uzzan; Maddalena QUARANTA EL-MAFTOUHI; Catherine Français-Maury; Wilfried Roquet; Laurent Castelnovo; Sam Razavi; Laetitia Finzi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3353.

ARVO Annual Meeting Abstract September 2016

Ranibizumab treatment according to the subtypes of choroidal neovascularisation due to neovascular Age-related Macular Degeneration in a real-life. 3 years interim analysis of a French national observational and multicentric retrospective study: COLOR.

David Sayag; Florence Coscas; Gerard Mimoun; Catherine Favard; Catherine Francais-Maury; Valerie Krivosic; Vincent Pierre-Kahn

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3368.

Retina June 2015

Restoration of Outer Retinal Layers After Aflibercept Therapy in Exudative AMD: Prognostic Value

PDF

Florence Coscas; Gabriel Coscas; Marco Lupidi; Ali Dirani; Mayer Srour; Oudy Semoun; Catherine Français; Eric H. Souied
TAGS: aflibercept, embryonic lethal mutation, patient prognosis, edema
Invest. Ophthalmol. Vis. Sci.. 2015; 56(6):4129-4134. https://doi.org/10.1167/iovs.15-16735

ARVO Annual Meeting Abstract June 2015

Usual Multimodal Imaging Versus Spectralis “En-Face” OCT 2 Angiography: a new semiologic approach in healthy and AMD patients.

Gabriel J Coscas; Florence Coscas; Marco Lupidi; Valérie Krivosic; Catherine Favard; Catherine Francais; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5930.

ARVO Annual Meeting Abstract June 2015

Early and delayed visual acuity responders to ranibizumab in patients with neovascular age-related macular degeneration: a retrospective pooled analysis from the real-world LUMIERE and TWIN studies

jean paul bellamy; Gérard Mimoun; Eric H Souied; Hassiba Oubraham; Catherine Français; Franck Rumen; Marie-Laure Lelez; Elisabeth Hermouet; Laetitia Finzi; Salomon Y Cohen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2823.

ARVO Annual Meeting Abstract June 2015

Ranibizumab for vascularized pigment epithelium detachment in neovascular age-related macular degeneration: a retrospective analysis from the 12-month real-world TWIN study

Violaine Caillaux; Hassiba Oubraham; Salomon Y Cohen; Gérard Mimoun; Catherine Francais; Franck Fajnkuchen; Ghislaine Ducos de Lahitte; Stephanie Agnes Baillif; Laetitia Finzi; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5360.

ARVO Annual Meeting Abstract June 2015

Recovery Of Ellipsoid Zone After Aflibercept Therapy For Exudative Age-Related Macular Degeneration.

Florence Coscas; Gabriel J Coscas; Ali Dirani; Marco Lupidi; Mayer Srour; Oudy Semoun; Catherine Français; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5384.

Retina January 2014

Comparison of Macular Choroidal Thickness in Adult Onset Foveomacular Vitelliform Dystrophy and Age-Related Macular Degeneration

PDF

Florence Coscas; Nathalie Puche; Gabriel Coscas; Mayer Srour; Catherine Français; Agnes Glacet-Bernard; Giuseppe Querques; Eric H. Souied
TAGS: adult, age-related macular degeneration, eye, vitelliform dystrophy, choroid
Invest. Ophthalmol. Vis. Sci.. 2014; 55(1):64-69. https://doi.org/10.1167/iovs.13-12931

ARVO Annual Meeting Abstract June 2013

Choroidal Thickness in Adult Onset Foveomacular Vittelliform Dystrophy and in Exudative Age-related Macular Degeneration

Florence Coscas; Nathalie Puche; Gabriel Coscas; Catherine Francais; Mayer Srour; Gerard Mimoun; Giuseppe Querques; Eric Souied

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4856.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration: A 24-Months Follow-up Study

Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration

Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study

Aflibercept polypoidal choroidal vasculopathy treatment : Result of a prospective study

Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naive patients enrolled in the ORACLE study

Ranibizumab treatment according to the subtypes of choroidal neovascularisation due to neovascular Age-related Macular Degeneration in a real-life. 3 years interim analysis of a French national observational and multicentric retrospective study: COLOR.

Restoration of Outer Retinal Layers After Aflibercept Therapy in Exudative AMD: Prognostic Value

Usual Multimodal Imaging Versus Spectralis “En-Face” OCT 2 Angiography: a new semiologic approach in healthy and AMD patients.

Early and delayed visual acuity responders to ranibizumab in patients with neovascular age-related macular degeneration: a retrospective pooled analysis from the real-world LUMIERE and TWIN studies

Ranibizumab for vascularized pigment epithelium detachment in neovascular age-related macular degeneration: a retrospective analysis from the 12-month real-world TWIN study

Recovery Of Ellipsoid Zone After Aflibercept Therapy For Exudative Age-Related Macular Degeneration.

Comparison of Macular Choroidal Thickness in Adult Onset Foveomacular Vitelliform Dystrophy and Age-Related Macular Degeneration

Choroidal Thickness in Adult Onset Foveomacular Vittelliform Dystrophy and in Exudative Age-related Macular Degeneration

To View More...

You must be signed into an individual account to use this feature.